BioGaia has signed an exclusive agreement with Abbott for the rights to commercialize BioGaia Protectis tabs in China. The product will be co-branded under BioGaia and Abbott brand. Launch of the product is planned to 2018.

BioGaia primarily focus on pediatrics, gut health and oral health and the probiotic products are available in around 90 countries.

'We have a strong focus on growing our Asian business and I am very pleased that yet another of BioGaia's products will be available in China. Based on the positive experience we already have in collaborating with Abbott in Latin America and Thailand, I look forward to a successful launch of BioGaia Protectis tabs with Abbott in China as well', says Axel Sjöblad, Managing Director, BioGaia.

Latest press releases from BioGaia
 2018-01-11 BioGaia Protectis with vitamin D soon in the Swedish market
2018-01-10 Two new meta-analyses confirm effectiveness of BioGaia's probiotic in infant colic
 2017-11-17 Lactobacillus reuteri reduced bone loss in older women

BioGaia AB published this content on 18 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 18 January 2018 08:24:04 UTC.

Original documenthttps://www.biogaia.com/pressrelease/biogaias-probiotic-to-be-launched-in-china/

Public permalinkhttp://www.publicnow.com/view/59EC94CFA7FD72FC0541F596A01CE8A5B6521821